Virios Therapeutics Llc Stock Shares Owned By Insiders
| VIRIDelisted Stock | USD 3.95 0.00 0.00% |
Virios Therapeutics Llc fundamentals help investors to digest information that contributes to Virios Therapeutics' financial success or failures. It also enables traders to predict the movement of Virios Stock. The fundamental analysis module provides a way to measure Virios Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Virios Therapeutics stock.
Virios |
Virios Therapeutics Llc Company Shares Owned By Insiders Analysis
Virios Therapeutics' Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Virios Therapeutics Shares Owned By Insiders | 6.74 % |
Most of Virios Therapeutics' fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Virios Therapeutics Llc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
CompetitionBased on the latest financial disclosure, 6.738% of Virios Therapeutics Llc are shares owned by insiders. This is 55.61% lower than that of the Biotechnology sector and 52.48% lower than that of the Health Care industry. The shares owned by insiders for all United States stocks is 33.22% higher than that of the company.
Virios Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Virios Therapeutics' direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Virios Therapeutics could also be used in its relative valuation, which is a method of valuing Virios Therapeutics by comparing valuation metrics of similar companies.Virios Therapeutics is currently under evaluation in shares owned by insiders category among its peers.
Virios Fundamentals
| Return On Equity | -1.2 | |||
| Return On Asset | -0.68 | |||
| Current Valuation | 1.28 M | |||
| Shares Outstanding | 1.11 M | |||
| Shares Owned By Insiders | 6.74 % | |||
| Shares Owned By Institutions | 3.60 % | |||
| Number Of Shares Shorted | 469.93 K | |||
| Price To Book | 1.37 X | |||
| EBITDA | 150.9 K | |||
| Net Income | (5.3 M) | |||
| Cash And Equivalents | 7.7 M | |||
| Cash Per Share | 0.92 X | |||
| Total Debt | 358.55 K | |||
| Current Ratio | 4.76 X | |||
| Book Value Per Share | 0.11 X | |||
| Cash Flow From Operations | (4.87 M) | |||
| Short Ratio | 0.64 X | |||
| Earnings Per Share | (5.75) X | |||
| Target Price | 3.0 | |||
| Beta | 1.58 | |||
| Market Capitalization | 172.1 K | |||
| Total Asset | 4.17 M | |||
| Retained Earnings | (61.47 M) | |||
| Working Capital | 3.81 M | |||
| Net Asset | 4.17 M |
About Virios Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Virios Therapeutics Llc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Virios Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Virios Therapeutics Llc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Consideration for investing in Virios Stock
If you are still planning to invest in Virios Therapeutics Llc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Virios Therapeutics' history and understand the potential risks before investing.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |